Therefore, the study proposes a novel therapeutic strategy: IFN-γ combined with IDO1 or AhR inhibitor can disrupt the dormancy of TRCs and induce their apoptosis, thus achieving more effective tumor clearance 44. This evidence concerns the gene IFNG and neoplasm.